Sequenom, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

SQNM 3.59 -0.06 (-1.64%)
price chart
Why Sequenom, Inc. Stock Skyrocketed
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Morning Buzz: Apple (AAPL), Sequenom Inc. (SQNM), MOL Global (MOLG ...  Wall Street Pit
Illumina and Sequenom Pool Noninvasive Prenatal Testing Intellectual ...  Business Wire (press release)
Related articles »  
Why Sequenom, Inc. Stock Scorched 23% Higher in December
What: Shares of Sequenom (NASDAQ: SQNM ) , a life sciences company focused on developing genomic and genetic analysis solutions and diagnostics, soared by 23% in December, based on data from S&P Capital IQ, after settling a long-standing legal ...
Why Sequenom Inc. Shares Surged
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Agena Bioscience Announces FDA 510(k) Premarket Clearance of the IMPACT ...  MarketWatch
Related articles »  
The Liquid Biopsy Will Boost Revenue For Sequenom And Illumina
The company sells equipment, reagents and service to the molecular testing space. Additionally, Illumina offers clinical genetic testing services through Verinata Health.
Sequenom Has Taken All The Right Steps To Reach Profitability (SQNM)
Sequenom, Inc. (NASDAQ:SQNM), a life sciences company, has been on quite the wild ride over the last several years. The company seems to have the business heading in the right direction and positioned for future success.
Related articles »  
Sequenom, Inc. Announces Participation At The 26th Annual Piper Jaffray ...
SAN DIEGO, Nov. 25, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the 2014 Piper Jaffray Healthcare Conference at the ...
Related articles »  
Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2014
SAN DIEGO, Nov. 4, 2014 /PRNewswire/ -- Sequenom, Inc. SQNM, +1.93% a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $37.9 million for the third quarter of 2014, an increase of 14% compared to ...
Sequenom's (SQNM) CEO Bill Welch on Q3 2014 Results - Earnings Call ...  Seeking Alpha (registration)
Related articles »  
Sequenom, Inc. v. The Board of Trustees of The Leland Stanford Junior ...
In its Final Written Decision, the Board found that Petitioner had not shown by a preponderance of the evidence any of challenged claims 1-17 of the '415 patent was unpatentable.
Related articles »  
Sequenom, Inc. Analyst Rating Update
Sequenom, Inc. (NASDAQ:SQNM) has received a Neutral rating, according to the latest recommendation of 3 from research firm, Zacks.
Sequenom Inc. Announces Participation At The 33rd Annual JP Morgan ...
SAN DIEGO Jan. 6 2015 /PRNewswire/ -- Sequenom Inc. (NASDAQ: SQNM) a leading molecular diagnostics company today announced the Company's participation at the 2015 J.P.
Related articles »